PCN3 Changes in Transfusion Burden (TB), Hemoglobin (Hb), Serum Ferritin (SF), and Iron Chelation Therapy (ICT) Use in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts Treated With Luspatercept From the MEDALIST Stu ...
Abstract
Authors
U. Platzbecker G. Garcia-Manero R.S. Komrokji D. Tang R. Ito S. Fabre G. Zhang X. Ha E. Mantovani D. Miteva T. Zinger P. Fenaux